Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Philippe Lechat

Showing results (101-110 of 110) with videos related to

Pageof 11
Sort By:
You have reached the last page of results.This site can display upto 110 results.
Therapie|December 15, 2023
How can the environmental sustainability of healthcare products be taken into account throughout their life cycle?Bruno Laviolle, Pierre-Frédéric Degon, Cécile Gillet-Giraud, et al.
Therapie|August 8, 2014
Information and communication on risks related to medications and proper use of medications for healthcare professionals and the general public: precautionary principle, risk management, communication during and in the absence of crisis situationsMathieu Molimard, Corine Bernaud, Philippe Lechat, et al.
Therapie|July 10, 2016
[Not Available]Mathieu Molimard, Corine Bernaud, Philippe Lechat, et al.
Therapie|July 10, 2016
[Not Available]Danièle Girault, Jean-Hugues Trouvin, Corinne Blachier-Poisson, et al.
Therapie|February 14, 2015
Biosimilars: from technical to pharmacoeconomic considerations. 30th Rencontres Nationales de Pharmacologie et Recherche clinique pour l'Innovation et l'Evaluation des Technologies de Santé. Tables rondesDanièle Girault, Jean-Hugues Trouvin, Corinne Blachier-Poisson, et al.
Therapie|July 10, 2016
Biosimilars: from Technical to Pharmacoeconomic ConsiderationsDanièle Girault, Jean-Hugues Trouvin, Corinne Blachier-Poisson, et al.
European Heart Journal|January 12, 2005
Randomized trial to determine the effect of nebivolol on mortality and cardiovascular hospital admission in elderly patients with heart failure (SENIORS)Marcus D Flather, Marcelo C Shibata, Andrew J S Coats, et al.
Annals of the Rheumatic Diseases|November 13, 2012
Hydroxychloroquine in systemic lupus erythematosus: results of a French multicentre controlled trial (PLUS Study)Nathalie Costedoat-Chalumeau, Lionel Galicier, Olivier Aumaître, et al.
Lupus Science & Medicine|November 8, 2014
Lower vitamin D levels are associated with higher systemic lupus erythematosus activity, but not predictive of disease flare-upYoland Schoindre, Moez Jallouli, Marie-Laure Tanguy, et al.
Revista Espanola De Cardiologia|December 25, 2004
[Expert Consensus document on angiotensin converting enzyme inhibitors in cardiovascular disease]José López-Sendón, Karl Swedberg, John McMurray, et al.
Pageof 11

Showing results (101-110 of 110) with videos related to

Sort By:
Pageof 11
You have reached the last page of results.This site can display upto 110 results.
Therapie|December 15, 2023
How can the environmental sustainability of healthcare products be taken into account throughout their life cycle?Bruno Laviolle, Pierre-Frédéric Degon, Cécile Gillet-Giraud, et al.
Therapie|August 8, 2014
Information and communication on risks related to medications and proper use of medications for healthcare professionals and the general public: precautionary principle, risk management, communication during and in the absence of crisis situationsMathieu Molimard, Corine Bernaud, Philippe Lechat, et al.
Therapie|July 10, 2016
[Not Available]Mathieu Molimard, Corine Bernaud, Philippe Lechat, et al.
Therapie|July 10, 2016
[Not Available]Danièle Girault, Jean-Hugues Trouvin, Corinne Blachier-Poisson, et al.
Therapie|February 14, 2015
Biosimilars: from technical to pharmacoeconomic considerations. 30th Rencontres Nationales de Pharmacologie et Recherche clinique pour l'Innovation et l'Evaluation des Technologies de Santé. Tables rondesDanièle Girault, Jean-Hugues Trouvin, Corinne Blachier-Poisson, et al.
Therapie|July 10, 2016
Biosimilars: from Technical to Pharmacoeconomic ConsiderationsDanièle Girault, Jean-Hugues Trouvin, Corinne Blachier-Poisson, et al.
European Heart Journal|January 12, 2005
Randomized trial to determine the effect of nebivolol on mortality and cardiovascular hospital admission in elderly patients with heart failure (SENIORS)Marcus D Flather, Marcelo C Shibata, Andrew J S Coats, et al.
Annals of the Rheumatic Diseases|November 13, 2012
Hydroxychloroquine in systemic lupus erythematosus: results of a French multicentre controlled trial (PLUS Study)Nathalie Costedoat-Chalumeau, Lionel Galicier, Olivier Aumaître, et al.
Lupus Science & Medicine|November 8, 2014
Lower vitamin D levels are associated with higher systemic lupus erythematosus activity, but not predictive of disease flare-upYoland Schoindre, Moez Jallouli, Marie-Laure Tanguy, et al.
Revista Espanola De Cardiologia|December 25, 2004
[Expert Consensus document on angiotensin converting enzyme inhibitors in cardiovascular disease]José López-Sendón, Karl Swedberg, John McMurray, et al.
Pageof 11